Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Amifostine for Chemotherapy Toxicity in Ovarian Cancer
NCT00004166Phase 3Completed
- Sponsor
- Northwestern University
- Start
- Oct 1999
- Primary completion
- Jan 2003
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of amifostine in ovarian epithelial cancer, sponsored by Northwestern University. Started Oct 1999; status: completed.
02
Drugs
amifostine
03
Conditions
ovarian epithelial cancer
Beyond the preview
Go deeper on NCT00004166.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00004166.